Investor clashes with Akorn board after botched Fresenius tie-up
An investor has urged an Illinois federal court to disregard Akorn’s motion to dismiss their lawsuit, after a merger between the drugmaker and healthcare company Fresenius collapsed following revelations that the drugmaker misrepresented the state of its data.
To read more
Subscribe to Global Data Review
Subscribe & start reading now!
The one-stop information source and community touchpoint, with coverage from across the areas of
- Data protection
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10